Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-01

Clinical Trial Update: The Effect of Scheduled Ripcord Removal on the Outcomes of Baerveldt 350 Implants [NA]

View source ↗

Summary

The study reports outcomes after scheduled Ripcord removal in Baerveldt 350 glaucoma implants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Baerveldt 350 implant

Snippet

Sponsor: Duke University | Conditions: Glaucoma | NA | Status: COMPLETED